Aspen Aerogels (NYSE:ASPN) Updates Q1 2025 Earnings Guidance

Aspen Aerogels (NYSE:ASPN) issued an update on its first quarter 2025 earnings guidance on Wednesday morning. The company provided EPS guidance of -0.180-0.000 for the period, compared to the consensus EPS estimate of 0.080. The company issued revenue guidance of $75.0 million-$95.0 million, compared to the consensus revenue estimate of $104.2 million.

Aspen Aerogels Stock Down 3.0 %

Shares of ASPN traded down $0.36 during mid-day trading on Wednesday, hitting $11.78. 4,444,883 shares of the company’s stock were exchanged, compared to its average volume of 1,624,350. The company has a debt-to-equity ratio of 0.27, a current ratio of 2.93 and a quick ratio of 2.48. Aspen Aerogels has a 52 week low of $10.67 and a 52 week high of $33.15. The company has a market cap of $966.55 million, a PE ratio of 1,179.18 and a beta of 2.14. The company has a 50-day simple moving average of $12.41 and a 200 day simple moving average of $18.68.

Aspen Aerogels (NYSE:ASPN) last released its earnings results on Wednesday, February 12th. The construction company reported $0.15 earnings per share for the quarter, beating analysts’ consensus estimates of $0.04 by $0.11. Aspen Aerogels had a net margin of 0.36% and a return on equity of 5.06%. On average, research analysts forecast that Aspen Aerogels will post 0.12 earnings per share for the current fiscal year.

Analysts Set New Price Targets

Several research firms have recently commented on ASPN. StockNews.com raised Aspen Aerogels to a “sell” rating in a report on Saturday. Barclays cut their price target on shares of Aspen Aerogels from $27.00 to $25.00 and set an “overweight” rating for the company in a research note on Tuesday, November 12th. HC Wainwright restated a “buy” rating and set a $30.00 price objective on shares of Aspen Aerogels in a research note on Wednesday, October 16th. Roth Mkm dropped their target price on shares of Aspen Aerogels from $36.00 to $31.00 and set a “buy” rating on the stock in a report on Friday, November 8th. Finally, Piper Sandler reduced their price target on Aspen Aerogels from $36.00 to $33.00 and set an “overweight” rating for the company in a report on Tuesday, October 22nd. One research analyst has rated the stock with a sell rating, eight have given a buy rating and one has assigned a strong buy rating to the company’s stock. According to data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average price target of $29.11.

Aspen Aerogels Company Profile

Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.